| 논문분류 | 춘계학술대회 초록집 |
|---|---|
| 제목 | Comparison of microvascular inflammation in renal allograft tissue between ABO incompatible and ABO compatible kidney transplantation |
| 저자 | Eun jeong KO, Bun soom CHOI, Cheol whee PARK, Yong-soo KIM, Chul woo YANG, *Byung ha CHUNG |
| 출판정보 | 2017; 2017(1): |
| 키워드 | ABO-incompatible kidney transplantation, microvascular inflammation |
| 초록 | Objectives : Microvascular inflammation (MVI) is considered as a pathological marker for antibody-mediated rejection (AMR) in the presence of donorspecific antibody (DSA). We aimed to investigate clinical role of MVI as predicting AMR in ABO incompatible kidney transplantation. (ABOi KT) Methods : A single-center retrospective matched cohort study was conducted. We evaluated histologic parameters in kidney biopsy of 296/75 ABO compatible (ABOc)/ABO incompatible (ABOi) consecutive living donor KT, matched for donor age and transplantation year. In the ABOi group, the desensitization protocol consisted of rituximab, plasmapheresis and immunoglobulins. Results : Between ABOc and ABOi group, there was no difference in deathcensored graft survival, and patient survival. (p-values for each 0.068. and 0.294) The cumulative incidence of acute rejection determined by both protocol biopsy and indication biospies was 19.5% and 23.2% (p=0.515) There was no difference in the incidence of MVI between ABOi KT and ABOc KT. (p=0.284) The incidence of MVI at protocol biopsy on post KT 3 months were not statistically different between ABOi and ABOc group. (p=0.103) High titer of Anti-A/B antibody didn’t correlated with the risk of MVI. (p=0.689) When compare ABOi KT to human leukocyte antigen (HLA) sensitized KT, highly- HLA-sensitized group (DSA Luminex MFI >5,000 or Pannel reactive antibody (PRA)>50%) showed tendency of increased rejection rate compared to lowsensitized group, despite of statistically insignificance. (p=0.311) And highly sensitized ABOi group had more frequently incidence of MVI than lowsensitized group (p<0.001). Conclusions : In contrast to HLA-DSA, ABO incompatibility or anti-A/B antibody titer was not associated with the development of MVI in allograft tissue. |
| 원문(PDF) | PDF 원문보기 |